Cite
MLA Citation
Zheng Li et al.. “ZLY032, the first-in-class dual FFA1/PPARδ agonist, improves glucolipid metabolism and alleviates hepatic fibrosis.” Pharmacological research, vol. 159, 2020, p. . http://access.bl.uk/ark:/81055/vdc_100106944426.0x00001d